Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer (Q46118058)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 November 2012

edit

Language	Label	Description	Also known as
English	Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer	scientific article published on 30 November 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

title

Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

author name string

Fausto Petrelli

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

Karen Borgonovo

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

Veronica Lonati

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

Stefano Elia

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

Sandro Barni

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

publication date

30 November 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

published in

Targeted oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

page(s)

291-294

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

cites work

Pattern and prognostic factors in patients with malignant ascites: a retrospective study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11523-012-0240-Y

retrieved

21 January 2018

The current and future management of malignant ascites

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11523-012-0240-Y

retrieved

21 January 2018

Malignant ascites: systematic review and guideline for treatment.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11523-012-0240-Y

retrieved

21 January 2018

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11523-012-0240-Y

retrieved

21 January 2018

Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11523-012-0240-Y

retrieved

21 January 2018

Frequent EpCam protein expression in human carcinomas

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11523-012-0240-Y

retrieved

21 January 2018

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11523-012-0240-Y

retrieved

21 January 2018

Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11523-012-0240-Y

retrieved

21 January 2018

Extraperitoneal response to intraperitoneal immunotherapy with catumaxomab in a patient with cutaneous lymphangiosis carcinomatosa from ovarian cancer: a case report and review of the literature

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS11523-012-0240-Y

retrieved

21 January 2018

High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23197249

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23197249

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current and future options in the treatment of malignant ascites in ovarian cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23197249

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathogenesis of malignant ascites.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23197249

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11523-012-0240-Y

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

PubMed publication ID

23197249

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23197249

retrieved

19 December 2017

reference URL

http://europepmc.org/abstract/MED/23197249

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46118058&oldid=2207648374"